Angioedema, a life-threatening adverse reaction to ACE-inhibitors

1. Sica DA, Black HR. ACE inhibitor-related angioedema: can angiotensin-receptor blockers be safely used? J Clin Hypertens. 2002;6(5):175-80. DOI: 10.1111/j.1524-6175.2002.01509.x.10.1111/j.1524-6175.2002.01509.x809938412368584Open DOISearch in Google Scholar

2. Sondhi D, Lippmann M, Murali G. Airway compromise due to angiotensin-converting enzyme inhibitor-induced angioedema. Chest. 2004;126(2):400-4. DOI: 10.1378/chest.126.2.400.10.1378/chest.126.2.40015302724Open DOISearch in Google Scholar

3. Peltekis G, Palaskas D, Samanidou M, Fragakis A, Alexopoulos K, Kotsani A, et al. Severe migratory angioedema due to ACE inhitiors use. Hippokratia. 2009;13(2):122-4.19561786Search in Google Scholar

4. Quincke HI. Uber akutes umschriebenes Hautodem. Monatshefte fur praktische Dermatologie. 1882;1:129-31.Search in Google Scholar

5. Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med. 2012;5:39. DOI: 10.1186/1865-1380-5-39.10.1186/1865-1380-5-39351825123131076Open DOISearch in Google Scholar

6. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005;53(3):373-88.10.1016/j.jaad.2004.09.0321611234316112343Open DOISearch in Google Scholar

7. Lang DM, Aberer W, Bernstein JA, Chng HH, Grumach AS, Hide M, et al. International consensus on hereditary and acquired angioedema. Ann Allergy Asthma Immunol. 2012;109(6):395-402. DOI: 10.1016/j.anai.2012.10.008.10.1016/j.anai.2012.10.00823176876Open DOISearch in Google Scholar

8. Vuzitas A, Sarafoleanu C. Hereditary angioedema – an otolaryngologist’s perspective. Rom J Rhinol. 2016;6(23):133-8. DOI: 10.1515/rjr-2016-0015.10.1515/rjr-2016-0015Search in Google Scholar

9. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602-16. DOI: 10.1111/all.12380. Epub 2014 Mar 27.10.1111/all.12380.Epub201427Open DOISearch in Google Scholar

10. Misra L, Khurmi N, Trent man TL. Agioedema: classification, management and emerging therapies for the perioperative physician. Indian J Anaesth. 2016;60(8):534-41. DOI: 10.4103/0019-5049.187776.10.4103/0019-5049.187776498980227601734Search in Google Scholar

11. Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P. Angiotensin converting enzyme inhibitor induced angio-edema: a review of the pathophysiology and risk factors. Clin Exp Allergy. 2010;40(1):50-61. DOI: 10.1111/j.1365-2222.2009.03323.x. Epub 2009 Jul 29.10.1111/j.1365-2222.2009.03323.x.Epub2009Jul29Open DOISearch in Google Scholar

12. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(4):1637-42.10.1001/archinte.165.14.163716043683Search in Google Scholar

13. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol. 1999;48(6):861-5. DOI: 10.1046/j.1365-2125.1999.00093.x.10.1046/j.1365-2125.1999.00093.xOpen DOISearch in Google Scholar

14. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol. 2008;100(4):327-32. DOI: 10.1016/S1081-1206(10)60594-7.10.1016/S1081-1206(10)60594-7Open DOISearch in Google Scholar

15. Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol. 1980;116(8):902–5.10.1001/archderm.1980.01640320052013Search in Google Scholar

16. Guyer Ac, Banerji A. ACE inhibitor-induced angioedema. [Internet]. Available from: https://www.uptodate.com/contents/ace-inhibitor-induced-angioedema. Accessed 21 September 2019.Search in Google Scholar

17. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351(9117):1693-7.10.1016/S0140-6736(97)09137-XSearch in Google Scholar

18. Morimoto T, Gandhi TK, Fiskio JM, Seger AC, So JW, Cook EF, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract. 2004;10(4):499-509.10.1111/j.1365-2753.2003.00484.x15482412Open DOISearch in Google Scholar

19. Kaplan AP, Ghebrehiwet B. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010;47(13):2161-9. DOI: 10.1016/j.molimm.2010.05.010.10.1016/j.molimm.2010.05.01020580091Open DOISearch in Google Scholar

20. Kalambay J, Ghazanfar H, Martes Pena KA, Munshi RA, Zhang G, Patel JY. Pathogenesis of drug induced non-allergic angioedema: a review of unusual etiologies. Cureus. 2017;9(8):e1598. DOI: 10.7759/cureus.1598.10.7759/cureus.1598565289329067222Search in Google Scholar

21. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005;53(3):373-88; quiz 389-92.10.1016/j.jaad.2004.09.03216112343Open DOISearch in Google Scholar

22. Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. Am J Med Sci. 2002;324(2):106-8.10.1097/00000441-200208000-0001112186104Search in Google Scholar

23. Eck SL, Morse JH, Janssen DA, Emerson SG, Markovitz DM. Angioedema presenting as chronic gastrointestinal symptoms. Am J Gastroenterol. 1993;88(3):436-9.Search in Google Scholar

24. Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, et al. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2013;131:1491-3. DOI: 10.1016/j.jaci.2013.03.034.10.1016/j.jaci.2013.03.03423726531Open DOISearch in Google Scholar

25. Bluestein HM, Hoover TA, Banerji AS, Camargo CA, Jr, Reshef A, Herscu P. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol. 2009;103:502–7. DOI: 10.1016/S1081-1206(10)60267-0.10.1016/S1081-1206(10)60267-0Open DOISearch in Google Scholar

26. Temiño VM, Peebles RS Jr. The spectrum and treatment of angioedema. Am J Med. 2008;121(4):282–6. DOI: 10.1016/j.amjmed.2007.09.024.10.1016/j.amjmed.2007.09.02418374684Open DOISearch in Google Scholar

27. Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Curr Allergy Asthma Rep. 2012;12(1):72-8. DOI: 10.1007/s11882-011-0238-z.10.1007/s11882-011-0238-z22127615Search in Google Scholar

28. Kyrmizakis DE, Papadakis CE, Liolios AD, Karatzanis AD, Malandrakis S, Skoulakis CE, et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg. 2004;130(12):1416-19. DOI: 10.1001/archotol.130.12.1416.10.1001/archotol.130.12.141615611402Open DOISearch in Google Scholar

29. Depetri F, Tedeschi A, Cugno M. Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment. Eur J Intern Med. 2019;59:8–13. DOI: 10.1016/j.ejim.2018.09.004. Epub 2018 Sep 13.10.1016/j.ejim.2018.09.004.Epub2018Sep13Open DOISearch in Google Scholar